Post Buyback Public Advertisement pursuant to and in compliance with Buyback Regulations. The Post Buyback Public Advertisement dated May 15, 2026 has been published in the newspapers on ....
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Ltd has completed its share buyback program. The company bought back 4,70,000 fully paid-up equity shares with a face value of INR 5 each at a price of INR 1,000 per share, totaling approximately INR 470 crore. The buyback was conducted on a proportionate basis and paid entirely in cash. The company published the post-buyback public advertisement in major newspapers on May 16, 2026, as required by SEBI (Buy-back of Securities) Regulations 2018. The shares were delisted from BSE (Scrip Code: 543329) and NSE (Symbol: WINDLAS). This announcement formally closes the buyback process that began earlier.
The buyback has reduced the company's total equity capital by 4,70,000 shares, which will improve per-share metrics like EPS for remaining shareholders. The significant premium to face value (1000 vs 5) indicates strong cash flow generation and reflects management confidence in the company's intrinsic value.